Olga A. Kuznetsova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olga A. Kuznetsova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alina V. Solovyeva
RUDN University
6 shared publications - Ekaterina Yu. Aleynikova
Peoples’ Friendship University of Russia named after Patrice Lumumba
4 shared publications - K. S. Ermolenko
Peoples’ Friendship University of Russia
3 shared publications - Larisa Alekseevna Chegus
Khanty-Mansiysk State Medical Academy
3 shared publications - Akhmetgaliev A.R. Akhmetgaliev
Kazan State Medical University
1 shared publication - Elena A. Vinokurova
Tyumen State Medical University
1 shared publication
Latest Publications
- Open Access
- 21 April 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 5,p. 106-113
Pregnancy complicated by iron deficiency anemia: does the problem have a solution?
Introduction. The problem of iron deficiency anemia by pregnant women remains relevant due to the wide spread of this complication (up to 40%) and requires the search for effective drugs with a minimum number of side effects.Aim. To improve perinatal outcomes in patients with iron deficiency anemia.Materials and methods. A retrospective analysis was done for 2020 of the medical records of patients, including an exchange card and birth histories. The patients were selected by a continuous sampling method. The study was conducted at the clinical base of the Department of Obstetrics and Gynecology with the course of perinatology of the Peoples’ Friendship University of Russia (Head of the Department, Corresponding Member of the Russian Academy of Sciences, Professor V.E. Radzinsky). All the patients (n = 114) were divided into three groups: the first group (n = 54) – a study group, which included pregnant women who had iron deficiency anemia in the II or III trimesters and received antianemic treatment; the second group (n = 30) – pregnant women with iron deficiency anemia (diagnosed in the 2nd trimester) who did not take iron supplements, the third group (n = 30) – a control group of women with normal hemoglobin levels during pregnancy and delivery.Results. The use of ferrous sulfate (Sorbifer durules) at a dose of 200 mg per day by pregnant women with IDA led to the fact that the weight-height parameters in newborns did not differ from those of children from healthy puerperas. At the same time, the volume of blood loss was greater in patients with IDA, however, there were no massive bleedings and moderate IDA in the postpartum period. The level of hemoglobin was significantly higher in women in labor who received ferrous sulfate (Sorbifer Durules) from the II trimester compared with pregnant women who had IDA in the III trimester. Thus, further research and the search for optimal dosages are required, as well as determining the most effective period for the use of iron supplements.Conclusions. Good tolerability and high efficacy of Sorbifer Durules in relation to a significant increase in hemoglobin and the absence of severe complications of pregnancy and childbirth associated with anemia allow us to recommend it for the treatment of IDA in pregnant women and puerperas.
- 21 April 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 5,p. 106-113
Open AccessPregnancy complicated by iron deficiency anemia: does the problem have a solution?
Introduction. The problem of iron deficiency anemia by pregnant women remains relevant due to the wide spread of this complication (up to 40%) and requires the search for effective drugs with a minimum number of side effects.Aim. To improve perinatal outcomes in patients with iron deficiency anemia.Materials and methods. A retrospective analysis was done for 2020 of the medical records of patients, including an exchange card and birth histories. The patients were selected by a continuous sampling method. The study was conducted at the clinical base of the Department of Obstetrics and Gynecology with the course of perinatology of the Peoples’ Friendship University of Russia (Head of the Department, Corresponding Member of the Russian Academy of Sciences, Professor V.E. Radzinsky). All the patients (n = 114) were divided into three groups: the first group (n = 54) – a study group, which included pregnant women who had iron deficiency anemia in the II or III trimesters and received antianemic treatment; the second group (n = 30) – pregnant women with iron deficiency anemia (diagnosed in the 2nd trimester) who did not take iron supplements, the third group (n = 30) – a control group of women with normal hemoglobin levels during pregnancy and delivery.Results. The use of ferrous sulfate (Sorbifer durules) at a dose of 200 mg per day by pregnant women with IDA led to the fact that the weight-height parameters in newborns did not differ from those of children from healthy puerperas. At the same time, the volume of blood loss was greater in patients with IDA, however, there were no massive bleedings and moderate IDA in the postpartum period. The level of hemoglobin was significantly higher in women in labor who received ferrous sulfate (Sorbifer Durules) from the II trimester compared with pregnant women who had IDA in the III trimester. Thus, further research and the search for optimal dosages are required, as well as determining the most effective period for the use of iron supplements.Conclusions. Good tolerability and high efficacy of Sorbifer Durules in relation to a significant increase in hemoglobin and the absence of severe complications of pregnancy and childbirth associated with anemia allow us to recommend it for the treatment of IDA in pregnant women and puerperas.
- Open Access
- 1 January 2023
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 11 (3)
Features of the course of pregnancy in women with menstrual cycle disorders and their correction with didrogesterone at the stage of pregravid preparation
Особенности беременности у женщин с нарушениями менструального цикла в анамнезе и их коррекция дидрогестероном на этапе прегравидарной подготовки
- 1 January 2023
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 11 (3)
Open AccessFeatures of the course of pregnancy in women with menstrual cycle disorders and their correction with didrogesterone at the stage of pregravid preparation
Особенности беременности у женщин с нарушениями менструального цикла в анамнезе и их коррекция дидрогестероном на этапе прегравидарной подготовки
- 1 January 2023
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 11 (suppl)
Oral probiotics: a dual action mechanism in correction of dysbiosis. What is known?
Пероральные пробиотики: механизм двойного действия в коррекции дисбиозов. Что известно?
- 1 January 2023
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 11 (suppl)
Oral probiotics: a dual action mechanism in correction of dysbiosis. What is known?
Пероральные пробиотики: механизм двойного действия в коррекции дисбиозов. Что известно?
- Open Access
- 20 April 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 5,p. 61-68
Status of biocenosis of vagina in pregnant women living in the Khanty-Mansi Autonomous Okrug–Yugra
Introduction. The intensive development of the mining industry led to a rapid growth in the population, large-scale migration processes to cities, the construction of numerous industrial facilities, which was accompanied by changes in the ecological, socioeconomic and cultural foundations of the local indigenous population (Khanty and Mansi) caused by the disruption of the usual rhythm of life that exists here. over the centuriesAim. The study of mass and growth parameters, the state of the biocenosis of the vagina and gastrointestinal tract in pregnant women living in the village and in the city in the Khanty-Mansi Autonomous Okrug-Yugra and correction of violations with metronidazole and miconazole.Materials and methods. A prospective analysis of complaints, anamnestic, anthropometric, as well as an assessment of the state of the biocenosis of the vagina and intestines in patients selected by the method of continuous sampling was carried out. We examined women from among the indigenous small-numbered peoples of the north (indigenous peoples of the North) – the Khanty and Mansi, living in the urban-type settlement. Berezovo, in camps and in the city of Khanty-Mansiysk. The comparison group included women from the migrant population (Russians) living in the city of Khanty-Mansiysk.Results. It was found that the greatest number of violations of the biocenosis of the vagina and intestines was in pregnant women living in the city, both from the indigenous minorities and the migrant population. Half of pregnant women, 50% of women, had normocenosis. Every second had inflammatory changes – nonspecific vaginitis occurred in 9.1%, vulvovaginal candidiasis in 13.6% and mixed pathogenic flora (bacterial vaginosis and vulvovaginal candidiasis) were in 31.8% of women. Monitoring of the state of the vaginal biocenosis was carried out after 4–5 weeks and at the end of the postpartum period (40–44 days), normobiocenosis was determined. Relapses both before and after childbirth within 42 days were not observed in this contingent.Conclusion. The use of metronidazole and miconazole intravaginally is an effective trea for bacterial vaginosis in combination with vulvovaginal candidiasis with rapid relief of symptoms and no side effects.
- 20 April 2022
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 5,p. 61-68
Open AccessStatus of biocenosis of vagina in pregnant women living in the Khanty-Mansi Autonomous Okrug–Yugra
Introduction. The intensive development of the mining industry led to a rapid growth in the population, large-scale migration processes to cities, the construction of numerous industrial facilities, which was accompanied by changes in the ecological, socioeconomic and cultural foundations of the local indigenous population (Khanty and Mansi) caused by the disruption of the usual rhythm of life that exists here. over the centuriesAim. The study of mass and growth parameters, the state of the biocenosis of the vagina and gastrointestinal tract in pregnant women living in the village and in the city in the Khanty-Mansi Autonomous Okrug-Yugra and correction of violations with metronidazole and miconazole.Materials and methods. A prospective analysis of complaints, anamnestic, anthropometric, as well as an assessment of the state of the biocenosis of the vagina and intestines in patients selected by the method of continuous sampling was carried out. We examined women from among the indigenous small-numbered peoples of the north (indigenous peoples of the North) – the Khanty and Mansi, living in the urban-type settlement. Berezovo, in camps and in the city of Khanty-Mansiysk. The comparison group included women from the migrant population (Russians) living in the city of Khanty-Mansiysk.Results. It was found that the greatest number of violations of the biocenosis of the vagina and intestines was in pregnant women living in the city, both from the indigenous minorities and the migrant population. Half of pregnant women, 50% of women, had normocenosis. Every second had inflammatory changes – nonspecific vaginitis occurred in 9.1%, vulvovaginal candidiasis in 13.6% and mixed pathogenic flora (bacterial vaginosis and vulvovaginal candidiasis) were in 31.8% of women. Monitoring of the state of the vaginal biocenosis was carried out after 4–5 weeks and at the end of the postpartum period (40–44 days), normobiocenosis was determined. Relapses both before and after childbirth within 42 days were not observed in this contingent.Conclusion. The use of metronidazole and miconazole intravaginally is an effective trea for bacterial vaginosis in combination with vulvovaginal candidiasis with rapid relief of symptoms and no side effects.
- 1 January 2022
- Published by Russian Vrach, Publishing House Ltd. in Врач
- Vol. 33 (8) , 56-61
The reproductive health of adolescent girls living in the Khanty-Mansiysk Autonomous Okrug - Yugra
- 1 January 2022
- Published by Russian Vrach, Publishing House Ltd. in Врач
- Vol. 33 (8) , 56-61
The reproductive health of adolescent girls living in the Khanty-Mansiysk Autonomous Okrug - Yugra
- Open Access
- 26 November 2021
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 23 (5) , 402-406
Comprehensive therapy with myoinositol and D-chiroinositol in a 5:1 ratio for abnormal uterine bleeding in overweight and obese women
Background. Abnormal uterine bleeding (AUB) occurs in one-third of women of reproductive age and has a significant impact on women's lives, causing anemia, impaired social adaptation and professional activity. AUB-O (ovulatory dysfunction) is often caused by an excessive body mass (BM) and obesity (especially visceral). The most effective option for restoring menstrual cycle (MC) in obese women is BM reduction. There is evidence that the combination of inositols myoinositol (MI) and D-chiroinositol (DCI) has a beneficial effect on BM loss, ovulation frequency and getting pregnant in women with polycystic ovary syndrome. Aim. To study the effect of MI and DHI in a 5:1 ratio in combination with diet and exercise on the regulation of MC in overweight and obese women. Materials and methods. The study has been conducted in clinics of Moscow, Kazan and Tyumen for 20202021. It is a descriptive study assessing an efficacy of lifestyle modification (diet and exercise) plus a nutritional support with a combination of 1000 mg MI and 200 mg DCI (ratio 5:1) for 24 months in 353 women of reproductive age with AMK-O and overweight or obesity. Efficacy criteria include: MC regularity, BM index (BMI), waist circumference (WC), levels of serum glucose, free testosterone, follicle-stimulating hormone, luteinizing hormone. Results. The study showed a significant shortening of MC to its physiological duration 3112.04 days (vs 4419.51 days at the 1st visit; p=0.001), a decrease in the rate of heavy bloody vaginal discharge by 2.57 times (p=0.001), an increase in the rate of moderate bloody vaginal discharge by 1,62 times (p=0.001), an increase in the proportion of patients with regular MC by 2.69 times (p=0.001). These changes were accompanied by a decrease in BM (-3 kg; p=0.001), a decrease in WC (-2.5 cm; p=0.001). Laboratory tests revealed a decrease in serum glucose (-1.3 mmol/L; p0.05), free testosterone (-0.4 pg/L; p0.05), luteinizing hormone (-0.8 mIU/ml; p0.05), and an increase in follicle-stimulating hormone (+0.1 mIU/ml; p0.05) levels. Conclusion. The results obtained (a decrease in BM, a decrease in BMI, WC, as well as MC restoration; p0.05) make it possible to recommend Dikirogen containing MI and DCI in a 5:1 ratio as a part of comprehensive therapy for overweight and obese women with AUB-O.
- 26 November 2021
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 23 (5) , 402-406
Open AccessComprehensive therapy with myoinositol and D-chiroinositol in a 5:1 ratio for abnormal uterine bleeding in overweight and obese women
Background. Abnormal uterine bleeding (AUB) occurs in one-third of women of reproductive age and has a significant impact on women's lives, causing anemia, impaired social adaptation and professional activity. AUB-O (ovulatory dysfunction) is often caused by an excessive body mass (BM) and obesity (especially visceral). The most effective option for restoring menstrual cycle (MC) in obese women is BM reduction. There is evidence that the combination of inositols myoinositol (MI) and D-chiroinositol (DCI) has a beneficial effect on BM loss, ovulation frequency and getting pregnant in women with polycystic ovary syndrome. Aim. To study the effect of MI and DHI in a 5:1 ratio in combination with diet and exercise on the regulation of MC in overweight and obese women. Materials and methods. The study has been conducted in clinics of Moscow, Kazan and Tyumen for 20202021. It is a descriptive study assessing an efficacy of lifestyle modification (diet and exercise) plus a nutritional support with a combination of 1000 mg MI and 200 mg DCI (ratio 5:1) for 24 months in 353 women of reproductive age with AMK-O and overweight or obesity. Efficacy criteria include: MC regularity, BM index (BMI), waist circumference (WC), levels of serum glucose, free testosterone, follicle-stimulating hormone, luteinizing hormone. Results. The study showed a significant shortening of MC to its physiological duration 3112.04 days (vs 4419.51 days at the 1st visit; p=0.001), a decrease in the rate of heavy bloody vaginal discharge by 2.57 times (p=0.001), an increase in the rate of moderate bloody vaginal discharge by 1,62 times (p=0.001), an increase in the proportion of patients with regular MC by 2.69 times (p=0.001). These changes were accompanied by a decrease in BM (-3 kg; p=0.001), a decrease in WC (-2.5 cm; p=0.001). Laboratory tests revealed a decrease in serum glucose (-1.3 mmol/L; p0.05), free testosterone (-0.4 pg/L; p0.05), luteinizing hormone (-0.8 mIU/ml; p0.05), and an increase in follicle-stimulating hormone (+0.1 mIU/ml; p0.05) levels. Conclusion. The results obtained (a decrease in BM, a decrease in BMI, WC, as well as MC restoration; p0.05) make it possible to recommend Dikirogen containing MI and DCI in a 5:1 ratio as a part of comprehensive therapy for overweight and obese women with AUB-O.